{"id":78467,"date":"2026-03-13T12:46:33","date_gmt":"2026-03-13T12:46:33","guid":{"rendered":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/"},"modified":"2026-03-13T12:46:33","modified_gmt":"2026-03-13T12:46:33","slug":"urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence","status":"publish","type":"post","link":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/","title":{"rendered":"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence"},"content":{"rendered":"<div>\n<ul>\n<li>National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50<\/li>\n<li style=\"margin-bottom:8pt;\">Many respondents report undergoing five or more cystoscopies, with some experiencing more than 15 procedures<\/li>\n<\/ul>\n<p>PRINCETON, N.J., March  13, 2026  (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd., a biotechnology company dedicated to developing innovative therapies for urothelial and specialty cancers, today commended the Bladder Cancer Advocacy Network (BCAN) on its release of <em>The New Faces of Bladder Cancer Report<\/em>, a national patient-reported survey underscoring the chronic and recurrent nature of bladder cancer.<\/p>\n<p>The survey, which captures the experiences of more than 1,100 bladder cancer patients across the United States, found that nearly 80% of respondents reported fear of recurrence, rising to more than 90% among patients under 50. Among women, 86% reported fear of recurrence, and among patients who retained their bladder, 87% reported ongoing concern. The report also documents the cumulative procedural burden associated with bladder cancer management, with a substantial proportion of patients reporting five or more cystoscopies and some experiencing more than 15 procedures over the course of their disease.<\/p>\n<p>\u201cThese findings reinforce what patients and clinicians experience every day \u2014 bladder cancer is often a chronic condition defined by recurrence, repeated procedures, and persistent uncertainty,\u201d said Mark Schoenberg, M.D., Chief Medical Officer of UroGen. \u201cWhen patients face years of surveillance and intervention, treatment discussions must consider not only tumor control but also long-term quality of life, personal priorities, and emotional burden. Elevating the patient voice through data of this scale is critical to improving care.\u201d<\/p>\n<p>Survey respondents represented diverse clinical experiences across all bladder cancer stages, including 47% initially diagnosed with non-muscle invasive bladder cancer (NMIBC), 23% with carcinoma in situ (CIS), and 22% with muscle-invasive disease (MIBC), with smaller proportions reporting advanced, metastatic, or upper tract urothelial carcinoma.<\/p>\n<p>\u201cThis report reflects the real burden of living with bladder cancer and the lasting impact of recurrence,\u201d said Meri-Margaret Deoudes, Chief Executive Officer of BCAN. \u201cWe thank UroGen for supporting this research, and for helping ensure that patient voices remain central to improving care.\u201d<\/p>\n<p>UroGen provided financial support for the survey and report. BCAN independently conducted the research and maintains full ownership and authorship of the findings.<\/p>\n<p>The full <em>New Faces of Bladder Cancer<\/em> report is available at: <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=aC9KmQ8XHoBgiNk502OpDE4JGeGNHLAf32vU0755HPBYgDeYUELS6yyP6wkWmli4Of1j6dE3iOT9WLEZ05LbRDry4cPlA9CHeyA31a2QAQ4=\" rel=\"nofollow\" target=\"_blank\" title=\"www.BCAN.org\/newfaces\">www.BCAN.org\/newfaces<\/a>.<\/p>\n<p><strong>About\u00a0UroGen Pharma Ltd.\u00a0<\/strong><br \/>UroGen is a biotech company dedicated to developing and commercializing innovative solutions that treat urothelial and specialty cancers because patients deserve better options. UroGen has developed\u00a0<em>RTGel<\/em>\u00a0reverse-thermal hydrogel, a proprietary sustained-release, hydrogel-based platform technology that has the potential to improve the therapeutic profiles of existing drugs. UroGen\u2019s sustained release technology is designed to enable longer exposure of the urinary tract tissue to medications, making local therapy a potentially more effective treatment option. Our first product is approved to treat low-grade upper tract urothelial cancer, and our second product, is approved for adult patients with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer. Both products are designed to ablate tumors by non-surgical means. UroGen is headquartered in\u00a0Princeton, NJ\u00a0with operations in\u00a0Israel. Visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Gh6dKa-gDewvnwHsKgZBi_WBc6SNtRkQq53lU1VHqy3fB-JqLb3v25DnAsMT09nvwkcjZ6jv7fjmYTVHFrLF1b1k6FJ9jPyYzs7OGmapPLkRVMCO1BVPHie6QmoMnBN8LpFcTgGqGyHFs7QeefoW9sldOwy_mXXjtLy1i8nUZowVgdKLpR4otlnuqgZjaaNocJTdYBPzjKdNVXfPm_CTXen3Kx5LC9jc3Sn8eXQjUdohBiWubleO6jep-vaXrdNSNEzY7TZ8AVNc9jYZdurDJLySWWpwl_CUBx0PEL92J70dpjcJkry6QhcCXXyXbHsCGKJZ3DYOqxhCqRo7dbhaY7Gg8KdXY1VjLC7k7HBBX0woIuKAVdlNYDzV9T99Tx-geZTNseX6CvhVj1X6Q4Np7020S7SYCufq4Iq8At3PRGIEgn9G2oC4Wq7HjA19bOjQSG07nFj3TAisdv8HXCANRbABudHePCdfjjjexhxDp6xLsrs-LwsftGgTNn9k6iJUs89dXZGG2Zk9ud23R08Z-QKyqxNmzfvzPySxKDE2Rfeb8h26i96L7iRkOAmNX3sw8UFf_z7fI943VNlNCeBl955JqC7qjBiiIL3Q6zJzd5twjG4v-xVvXWpWIYh9JXcCfEQT0KLMJsdjA5HwBG7y0GIfuYMAD2G6G9hENMaPD1U13l1SgtfieP7WXC12N3anEeN4oCYeBYzZCxKmGXc8itqr6OtbJvGCZ9vFTrL0y89vnRDP_qp45nQIPU9DxIFyy_R1pSK_-ZjE-4lTvbUwoP8-hUFbHQdBeFa6rs01nqv-Yy-OqYbdwcSgOyRWSO_etxK9BHLXWUog_eJO8SN--qIaeQ1uZBKN76jz3SHzu77-w7HvU08iGe3en533ER9FQZXfYxaE0_kk14qcjQov5Tsu5vIhu9aEwDA8owV4iLif0etijFEaMXSa1gs2lFffbOTzE559Y7RpZXDTAAXs8TYJJiCFUmq2BsijwoHiZQdmqFWd0MQqqsmUDYkEpriojJm-lBGeIhokc7s_zuMH5eSlXEKcfvmz0i0FL_MYp97_cPEFLnYw20akT71sba-Q\" rel=\"nofollow\" target=\"_blank\" title=\"\"><strong>www.UroGen.com<\/strong><\/a>\u00a0to learn more or follow us on X, @UroGenPharma.<\/p>\n<p align=\"left\"><strong>INVESTOR CONTACT:<\/strong><br \/>Vincent Perrone<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=zIswUHQ8ux-mYxUFDt-dJ4G_E96wenSiChSIOvfxRR7_l7NtiXp-zM6OpRTIjAl3UQ_VzCgWZWVSM-qv2o5TXzKzHbJsjTSC3Embdk5XpWio5jYmJzeFG-ptHSDcX_WO\" rel=\"nofollow\" target=\"_blank\" title=\"vincent.perrone@urogen.com\">vincent.perrone@urogen.com<\/a><br \/>(609) 460-3588 Ext. 1093<\/p>\n<p align=\"left\"><strong>MEDIA CONTACT:<\/strong><br \/>Cindy Romano<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=f4fJ3T-NwlUoh5WIBK_p38in87iR1ldUGW-sy_XvcEbuDXySkqzw04fZh3xnixxOVjQ8uCG0CAuCrJ0mcnCNqlxGCHOmwpa1buW0t9NrLldoYBEWQDOaAYEYva6MfIA9\" rel=\"nofollow\" target=\"_blank\" title=\"Cindy.romano@urogen.com\">Cindy.romano@urogen.com<\/a><br \/>(609) 460-3566 Ext. 1083<\/p>\n<p><img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/MTA5YjMwMWMtYmUxMC00NjZjLThmNDMtMTExYTQxMzcyYzM0LTEwNDA1OTAtMjAyNi0wMy0xMy1lbg==\/tiny\/UroGen-Pharma-Ltd-.png\" referrerpolicy=\"no-referrer-when-downgrade\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50 Many respondents report undergoing five or more cystoscopies, with some experiencing more than 15 procedures PRINCETON, N.J., March 13, 2026 (GLOBE NEWSWIRE) &#8212; UroGen Pharma Ltd., a biotechnology company dedicated to developing [&#8230;]\n","protected":false},"author":1,"featured_media":78468,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-78467","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pr-newswire"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v21.6 (Yoast SEO v21.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence - Biz and Live in Saigon<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence\" \/>\n<meta property=\"og:description\" content=\"National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50 Many r\" \/>\n<meta property=\"og:url\" content=\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\" \/>\n<meta property=\"og:site_name\" content=\"Biz and Live in Saigon\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SaigonbizGroup\" \/>\n<meta property=\"article:published_time\" content=\"2026-03-13T12:46:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/ml.globenewswire.com\/media\/MTA5YjMwMWMtYmUxMC00NjZjLThmNDMtMTExYTQxMzcyYzM0LTEwNDA1OTAtMjAyNi0wMy0xMy1lbg==\/tiny\/UroGen-Pharma-Ltd-.png\" \/>\n<meta name=\"author\" content=\"admin\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"admin\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\"},\"author\":{\"name\":\"admin\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\"},\"headline\":\"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence\",\"datePublished\":\"2026-03-13T12:46:33+00:00\",\"dateModified\":\"2026-03-13T12:46:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\"},\"wordCount\":548,\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"articleSection\":[\"Pr Newswire\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\",\"name\":\"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence - Biz and Live in Saigon\",\"isPartOf\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\"},\"datePublished\":\"2026-03-13T12:46:33+00:00\",\"dateModified\":\"2026-03-13T12:46:33+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/english.saigonbiz.com\/vn\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#website\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"name\":\"Biz and Live in Saigon\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#organization\",\"name\":\"SaigonBiz Media\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png\",\"width\":512,\"height\":512,\"caption\":\"SaigonBiz Media\"},\"image\":{\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SaigonbizGroup\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6\",\"name\":\"admin\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"contentUrl\":\"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png\",\"caption\":\"admin\"},\"sameAs\":[\"https:\/\/english.saigonbiz.com\/vn\"],\"url\":\"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence - Biz and Live in Saigon","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/","og_locale":"en_US","og_type":"article","og_title":"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence","og_description":"National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under 50 Many r","og_url":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/","og_site_name":"Biz and Live in Saigon","article_publisher":"https:\/\/www.facebook.com\/SaigonbizGroup","article_published_time":"2026-03-13T12:46:33+00:00","og_image":[{"url":"https:\/\/ml.globenewswire.com\/media\/MTA5YjMwMWMtYmUxMC00NjZjLThmNDMtMTExYTQxMzcyYzM0LTEwNDA1OTAtMjAyNi0wMy0xMy1lbg==\/tiny\/UroGen-Pharma-Ltd-.png"}],"author":"admin","twitter_card":"summary_large_image","twitter_misc":{"Written by":"admin","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/#article","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/"},"author":{"name":"admin","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6"},"headline":"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence","datePublished":"2026-03-13T12:46:33+00:00","dateModified":"2026-03-13T12:46:33+00:00","mainEntityOfPage":{"@id":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/"},"wordCount":548,"publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"articleSection":["Pr Newswire"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/","url":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/","name":"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence - Biz and Live in Saigon","isPartOf":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#website"},"datePublished":"2026-03-13T12:46:33+00:00","dateModified":"2026-03-13T12:46:33+00:00","breadcrumb":{"@id":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/english.saigonbiz.com\/vn\/urogen-applauds-bcans-new-faces-of-bladder-cancer-report-highlighting-recurrence-burden-and-fear-of-recurrence\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/english.saigonbiz.com\/vn\/"},{"@type":"ListItem","position":2,"name":"UroGen Applauds BCAN\u2019s New Faces of Bladder Cancer Report Highlighting Recurrence Burden and Fear of Recurrence"}]},{"@type":"WebSite","@id":"https:\/\/english.saigonbiz.com\/vn\/#website","url":"https:\/\/english.saigonbiz.com\/vn\/","name":"Biz and Live in Saigon","description":"","publisher":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/english.saigonbiz.com\/vn\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/english.saigonbiz.com\/vn\/#organization","name":"SaigonBiz Media","url":"https:\/\/english.saigonbiz.com\/vn\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/cropped-c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview.png","width":512,"height":512,"caption":"SaigonBiz Media"},"image":{"@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SaigonbizGroup"]},{"@type":"Person","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/267b348e6cf32a66aab33637c2d399a6","name":"admin","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/english.saigonbiz.com\/vn\/#\/schema\/person\/image\/","url":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","contentUrl":"https:\/\/english.saigonbiz.com\/vn\/wp-content\/uploads\/2026\/03\/c2adea16-1c71-4315-8801-803a8d237e2a_removalai_preview-2_uwp_avatar_thumb.png","caption":"admin"},"sameAs":["https:\/\/english.saigonbiz.com\/vn"],"url":"https:\/\/english.saigonbiz.com\/vn\/profile\/admin\/"}]}},"_links":{"self":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/78467","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/comments?post=78467"}],"version-history":[{"count":0,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/posts\/78467\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media\/78468"}],"wp:attachment":[{"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/media?parent=78467"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/categories?post=78467"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/english.saigonbiz.com\/vn\/wp-json\/wp\/v2\/tags?post=78467"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}